Evidence map›Paper›PMID 34442851›Full record

ArticleMicroorganisms2021

Latin American Origin Is Not Associated with Worse Outcomes among Hospitalized Patients with COVID-19 in a Public Healthcare System.

Silvia Otero-Rodriguez, Oscar Moreno-Pérez, Jose Manuel Ramos, Mar García, Vicente Boix, Sergio Reus, Diego Torrus, Pablo Chico-Sánchez, José Sánchez-Payá, Fernando Aldana-Macias and 4 more

Abstract read
In one paragraph

Article in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Silvia Otero-RodriguezAlicante Institute of Health and Biomedical Research (ISABIAL), 03010 Alicante, Spain.ORCID 0000-0002-7801-5072
Oscar Moreno-PérezAlicante Institute of Health and Biomedical Research (ISABIAL), 03010 Alicante, Spain.ORCID 0000-0002-8670-6404
Jose Manuel RamosAlicante Institute of Health and Biomedical Research (ISABIAL), 03010 Alicante, Spain.ORCID 0000-0002-6501-9867
Mar GarcíaAlicante Institute of Health and Biomedical Research (ISABIAL), 03010 Alicante, Spain.
Vicente BoixAlicante Institute of Health and Biomedical Research (ISABIAL), 03010 Alicante, Spain.
Sergio ReusAlicante Institute of Health and Biomedical Research (ISABIAL), 03010 Alicante, Spain.ORCID 0000-0002-3320-9754
Diego TorrusAlicante Institute of Health and Biomedical Research (ISABIAL), 03010 Alicante, Spain.
Pablo Chico-SánchezAlicante Institute of Health and Biomedical Research (ISABIAL), 03010 Alicante, Spain.ORCID 0000-0003-2809-8751
José Sánchez-PayáAlicante Institute of Health and Biomedical Research (ISABIAL), 03010 Alicante, Spain.
Fernando Aldana-MaciasAlicante Institute of Health and Biomedical Research (ISABIAL), 03010 Alicante, Spain.
Joan GilAlicante Institute of Health and Biomedical Research (ISABIAL), 03010 Alicante, Spain.
Joaquín PortillaAlicante Institute of Health and Biomedical Research (ISABIAL), 03010 Alicante, Spain.ORCID 0000-0002-3676-9511
Esperanza MerinoAlicante Institute of Health and Biomedical Research (ISABIAL), 03010 Alicante, Spain.
On Behalf Of Covid Alc Research Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exploring differences in clinical outcomes based on race and origin among patients hospitalized for COVID-19 is a controversial issue. The ALC COVID-19 Registry includes all confirmed COVID-19 patients admitted to hospital from 3 March 2020 to 17 December 2020. The data were obtained from electronic health records in order to evaluate the differences in the clinical features and outcomes among European and Latin American patients. The follow-ups occurred after 156 days. A propensity score weighting (PSW) logistic regression model was used to estimate the odds ratio (OR, 95% CI) for Latin American origin and outcome associations. Of the 696 patients included, 46.7% were women, with a median age of 65 (IQR 53-67) years, 614 (88.2%) were European, and 82 (11.8%) were Latin American. Latin American patients were younger, with fewer comorbidities, and a higher incidence of extensive pneumonia. After adjusting for residual confounders, Latin American origin was not associated with an increased risk of death (PSW OR 0.85 (0.23-3.14)) or with the need for invasive mechanical ventilation (PSW OR 0.35 (0.12-1.03)). Latin American origin was associated with a shorter hospital stay, but without differences in how long the patient remained on mechanical ventilation. In a public healthcare system, the rates of death or mechanical ventilation in severe COVID-19 cases were found to be comparable between patients of European and Latin American origins.

Indexed as

COVID-19Latin Americanmortalityoriginoutcomerace

Identifiers

PMID34442851
PMCPMC8398476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.